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Structural alterations of the cellular prion protein (PrP
C) seem to be the core of the
pathogenesis of prion diseases. However, the physiological function of PrP
C remains
an enigma. Cell culture experiments have indicated that PrP
C and in particular its N-
terminal octarepeat region together with the phosphatidylinositol 3-kinase (PI3K)/Akt
signaling pathways have a fundamental involvement in neuroprotection and oxidative
stress reactions. We used wild-type mice, PrP knockout (Prnp
-/-)
 animals and transgenic
mice that lack the octarepeat region (C4/-) and subjected them to controlled ischemia.
We identiﬁed an increased cleavage and synthesis of PrP
C in ischemic brain areas of
wild-type mice compared with sham controls. The infarct size in Prnp
-/- animals was
increased threefold when compared with wild-type mice. The infarct size in C4/- ani-
mals was identical to Prnp
-/- mice, that is, around three times larger than in wild-type
mice. We showed that the PrP in C4/- mice does not functionally rescue the Prnp
-/-
phenotype; furthermore it is unable to undergo b cleavage, although an increased
amount of C1 fragments was found in ischemic brain areas compared with sham con-
trols. We demonstrated that the N-terminal octarepeat region has a lead function in
PrP
C physiology and neuroprotection against oxidative stress in vivo.
Brain Pathol 2007;17:174–183.
INTRODUCTION
The cellular prion protein (PrP
C) is a
copper-binding protein (3, 17) located at
the synapse (13) and has a primary role in
the pathogenesis of prion diseases. A tem-
plated conformational transition of PrP
C
seems to be the cause of transmissibility
and pathogenesis (25). PrP
C  has been
shown to play a role in cellular antioxida-
tive defense mechanisms (15, 27) and to
protect human neurons in primary culture
against Bax-mediated cell death (2). Exper-
iments in cerebellar granule cells (5) have
shown a loss of neuroprotective activity of
PrP
C by a deletion of all ﬁve N-terminal
octarepeats (PrP∆51–90). We have
recently identiﬁed a functional link
between PrP
C  expression and phosphati-
dylinositol 3-kinase (PI3K) activation, a
regulator of Akt phosphorylation and a
protein kinase that plays a pivotal role in
cell survival (33). Our ﬁndings are in
agreement with published results that
showed reduced Phospho-Akt expression
levels in Prnp
−/−  mouse brains following
ischemia (38). We could also demonstrate
that hippocampal cells that lack the octare-
peat region showed reduced PI3K levels
and decreased survival under stress condi-
tions similar to PrP
C knockout cells.
In  neuroblastoma cells it could be
demonstrated that the octapeptide repeats
are required for the β  cleavage and
their absence (PrP∆oct) correlates with
increased sensitivity of cells to oxidative
stress (36). The cleavage of the molecule
seems to play a major role in the biological
properties of PrP
C but succession of these
proteolysis procedures as well as relations
between the two cleavages is controversial
and still remains to be elucidated and in
particular, the relevance of the octapeptide
region in this functional process has not
been established in vivo.
Recently, brain injury models in mice
have been used to investigate a potential
neuroprotective role of PrP
C in vivo (14,
21, 31, 37). There were signiﬁcant differ-
ences between the volume of the lesion in
PrP knockout (Prnp
−/−) mice when com-
pared with the wild-type counterpart with
larger area of injury in the former. More-
over, using in situ hybridization an increase
of PrP mRNA levels and also PrP immu-
noreactivity were detected in penumbral
neurons of the ischemic lesion (21). These
results further support the hypothesis of
the antioxidant function of PrP
C in vivo.
With this work we specify the neuropro-
tective property of PrP
C and the role of the
octarepeat region in this function and con-
tribute to understanding the succession
and signiﬁcance of cleavage processes in an
in vivo ischemic model. We used transgenic
C4/− mice that lack the octarepeat region
of PrP
C (6). We challenged C4/−, Prnp
−/−
and  Prnp
+/+  mice in a focal cerebral
ischemia model. Prnp
−/−  and C4/−  mice
showed largely increased infarct volumes
when compared with wild-type littermates.
The C4 protein (PrP∆32–93) did not
functionally rescue the Prnp
−/− phenotype,
the octapeptide region of PrP
C  therefore
seems to play a key role in neuroprotection.
MATERIALS AND METHODS
Transgenic mice. We used homologous
Prnp
+/− recombination to produce Prnp
+/+
and Prnp
−/− littermates with a 129/Sv-C57/
Bl6 background. The role of the octarepeat
region was investigated in C4/− mice lack-
ing amino acids 32 to 93 of PrP
C (30). In
consideration of the Prnp
−/− background of
C4/−  mice and the PrP
C  expression, we
crossed hemizygous C4/− and Prnp
−/− mice
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to obtain male (21–28  g) hemizygous
C4/−  and  Prnp
−/−  littermates. Published
polymerase chain reaction (PCR) protocols
to identify the transgenes on the Prnp
−/−
background or wild-type and Prnp
−/− mice
were used (30). In agreement with previous
ﬁndings published by Shmerling and
coworkers (30), we detected higher PrP
expression in C4/− animals in comparison
with wild-type control mice, that is,
approximately three times higher in
homozygous and 1.5 times higher in hem-
izygous C4/− mice (data not shown). All
C4 mice used in this study were hemizy-
gous C4/−. The mice were assigned to four
groups: G1 (Prnp
−/−; n = 9), G2 (Prnp
+/+;
n =  7), G3 (C4/−; n  =  8), G4 (Prnp
−/−;
n =  8). They were kept under standard
diurnal conditions and allowed access to
food and water ad libitum. The animal
experiments were in accordance with ani-
mal protection standards and were
approved by the government of Upper
Bavaria (protocol number 209.1-2531-81/
01). Every effort was made to reduce the
number of animals used and to ensure they
were free of pain and discomfort.
Surgical procedure.  The intraluminal
ﬁlament model was used for occlusion of
the middle cerebral artery (MCAO) (35).
After 1  h of ischemia reperfusion was
induced by withdrawing the thread, the
animals were then sacriﬁced after 24  h.
Brieﬂy, mice were anesthetized with 3%
isoﬂurane (Forene, Abbott, Germany) for
induction and maintained on 1.5% in a
70%/30% mixture of N2O/O2  adminis-
tered via a face mask. The rectal tempera-
ture was maintained at 37  ± 0.5°C with
a homeothermic blanket system. The
regional cerebral blood ﬂow (rCBF) was
recorded in all animals using laser Doppler
ﬂowmetry (Perimed, Järfäla, Sweden) in
which a ﬁberoptic probe placed over the
MCA territory 2 mm posterior and 6 mm
lateral of the bregma (12). After ventral
midline neck incision, the left common
and external carotid arteries were ligated.
The internal carotid artery (ICA) was tem-
porarily clipped with a microvascular clip
(Aesculap, Tuttlingen, Germany), and a
silicon-coated 8-0 nylon monoﬁlament
(Ethicon, Johnson&Johnson, Norderstedt,
Belgium) was gently advanced into the
ICA. The baseline rCBF values were
reduced by >70%. The tip diameter of the
thread was selected to match the body
weight of the animals. After surgery, the
laser Doppler probes were removed, and
mice were allowed to wake up and return
to their cages. Reperfusion was initiated by
withdrawing the thread under short inha-
lation anesthesia. At the end of the reper-
fusion period, the mice were sacriﬁced in
deep anesthesia by transcardial perfusion
with cold isotonic saline solution contain-
ing bovine serum albumin (5 g/L), heparin
(10 IU/L) and 2 mL nitroprusside sodium
(100 µL, 18 mg in 10 mL saline) solution.
Brains were removed, and the skull base
was inspected for hemorrhage. In addition,
four sham-operated mice underwent the
same surgical procedures, but in these mice
the ﬁlament was only introduced into the
common carotid artery; this does not lead
to brain infarction. The neurological out-
come was deﬁned in all animals according
to Garcia et  al (7). It is deﬁned by a
sequence of six physiological tasks: (i)
spontaneous activity, (ii) symmetry in the
movement, (iii) forepaw outstretching, (iv)
climbing, (v) body proprioception, and
(vi) response to vibrissae touch. The overall
score is 18 points. In all surgical procedures
and following experiments the investiga-
tors were blinded as to the experimental
groups individual mice belonged to.
Preparation of frozen sections.  Frozen
sections of 10-µm thickness were collected
on pre-labeled glass slides at −20°C. Every
50th section was used for volumetric anal-
ysis; the remaining sections were stored at
−80°C. For Western blotting and reverse
transcriptase polymerase chain reaction
(RT-PCR), frozen coronal sections were
prepared, Nissl-stained and divided using
a scalpel and a dissecting microscope into
three regions, that is, necrotic infarct area
(N), ipsilateral non-necrotic hemisphere
(I), and contralateral hemisphere (C) to
detect different progressions of the damage
in dependence on the injury distance
(Figure 1A).
Infarct deﬁnition and volumetry. Nissl
staining was used to delineate infarct
lesions. To calculate the infarct and hemi-
spheric volumes, the method described by
Kloss et  al (16) was used. Brieﬂy, Nissl-
stained consecutive sections with 500-µm
clearance were digitized using a ﬂatbed
scanner (Epson, Meerbusch, Germany).
The ﬁles were imported into Optimas
imaging software, the lesions and hemi-
spheres delineated, and the size converted
into the metric system. Next, partial vol-
umes between two adjacent sections were
computed using the formula for a conic
section:
with area 1,2,3, . . . n−1 being the partial area
of the lesion of the serial sections. The
total hemisphere volumes were calculated
equally and ﬁnally the ratio of infarct vol-
ume vs. the total hemispheric volume was
deﬁned.
Quantitative RT-PCR (QRT-PCR).
Immediately prior to RNA isolation, slides
containing frozen sections were ﬁxed in
75% ethanol for 45  s and Nissl-stained.
Subsequently, the slides were dehydrated
in graded ethanol solutions for 5  s each
and air-dried. RNA isolation from Nissl-
stained sections was performed by using
RNeasy Micro Kit (Qiagen, Hilden, Ger-
many). Brieﬂy, materials in particular brain
regions (N, I and C) as described above
were scraped and lysed with buffer RLT.
Materials in a particular region from eight
sections each animal were pooled and
RNAs isolated according to the protocol
recommended by Qiagen. The quantity of
RNA was assessed using the NanoDrop
®
ND-1000 Spectrophotometer (Nano-
Drop, Wilmington, DE, USA).
Four hundred nanograms of RNA
was used to make single-stranded cDNAs
(Superscript II; Invitrogen, Karlsruhe, Ger-
many) according to the manufacturer’s
instructions. Using 2  µL diluted cDNA
(1:10), real-time quantitative PCR was car-
ried out with Faststart Plus DNA Master
SYBR Green I on LightCycler (Roche,
Mannheim, Germany) under the following
conditions: 95°C for 10 minutes for a hot
start, followed by denaturing at 95°C for
10 s, annealing at 57°C for 5 s, and exten-
sion at 72°C for 10 s for 45 cycles. Primer
sets used for PCRs were as follows: for β-
actin (9) (with modiﬁcation), 5′  AAC
CCT AAG GCC AAC CGT GAA AAG
3′  and 5′  CTA GGA GCC AGA GCA
GTA ATC T 3′; for prion protein gene
lesion volume
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(Prnp), 5′ CCA ATT TAG GAG AGC C
3′ and 5′ GCT TCC CTG CCC GGG
ATA CC 3′. Calibrator-normalized relative
quantiﬁcation was performed by LightCy-
cler Software version 4.0 (Roche).
Immunohistochemical staining proce-
dures.  Coronal frozen sections were pre-
treated including dehydration, short
ﬁxation in 0.25% glutaraldehyde and
heat-reliant epitope retrieval. Afterwards,
nonspeciﬁc protein binding sites were
blocked with 10% normal goat serum fol-
lowed by incubation of the respective pri-
mary antibody. For PrP staining in Prnp
+/+
mice, an antiserum puriﬁed from a rabbit
immunized against recombinant full-
length mouse PrP was used (CDC1),
whereas 1A8, an antiserum puriﬁed from
a rabbit immunized against the C-terminal
domain (amino acids 89–234) of mouse
PrP was used in C4/− mice. The polyclonal
antibody Actin I-19 against β-actin was
obtained from Santa Cruz (Biotechnology,
Heidelberg, Germany). The primary
antibody was detected by a biotinylated
secondary antibody and enhanced by
streptavidin alkaline phosphatase com-
plexes. Visualization of immunoreactivity
followed by using Fast Red or DAB as the
chromogen. Counterstaining followed
with hemalaun. For immunoﬂuorescence
staining, a streptavidin CY3 conjugate was
Figure 1. Histology after middle cerebral artery occlusion for 1-h ischemia and 24-h reperfusion time. A. Nissl-stained sections at the level of the bregma, the
maximal extent of the infarct in Prnp
−/− and Prnp
+/+ mice. Necrotic areas show a very faint staining. Frozen coronal sections were divided into three regions,
that is, necrotic infarct area (N), ipsilateral non-necrotic hemisphere (I) and contralateral hemisphere (C). B. Immunoﬂuorescence for cellular prion protein
(PrP
C) in a Prnp
+/+ mouse after cerebral ischemia using polyclonal antibody CDC1 and Fast Red as chromogen. There is strong staining for PrP
C in all gray matter
areas except the infarct zone on the left. C. Immunohistochemistry with polyclonal antibody CDC1. This formalin-ﬁxed and parafﬁn-embedded section shows
a number of strongly stained neurons in the area adjacent to the infarct, while other neurons and glial cells in this section appear negative. D. No reaction
with the antibody directed against PrP was detected in frozen sections of the Prnp
−/− littermates. E. Immunoﬂuorescence for PrP
C in Prnp
+/+ mouse brains after
cerebral ischemia using polyclonal antibody CDC1 and DAB as the chromogen. This frozen section shows again a number of strongly stained neurons in the
area adjacent to the infarct. F.  Immunoﬂuorescence for PrP
C in C4/− mouse brains after cerebral ischemia using polyclonal antibody 1A8 and DAB as the
chromogen. Punctate PrP staining of intensely immunoreactive neuronal cells is seen especially in the ipsilateral area surrounding the infarct. G. No reaction




EF GNeuroprotective Function of PrP
C—Mitteregger et al 177
© 2007 The Authors
Journal Compilation © 2007 International Society of Neuropathology • Brain Pathology
used instead of streptavidin alkaline phos-
phatase complexes. The nuclei were
counterstained with 4′,6-diamidino-2-
phenylindole dihydrochloride and slides
were covered in aqueous solution. Staining
of parafﬁn sections was performed after
deparafﬁnizing the sections in xylene.
Immunoblotting. The process was per-
formed as described in our previous data
(18). According to the size, different
regions (N, I and C) on the Nissl-stained
coronal frozen sections were solubilized by
adding 5 µL of lysis buffer (with 2% SDS
and 0.5 M DTT) on N, 10 µL on I and
15 µL on C. Identical regions were solubi-
lized in the same volumes of buffer in
sham-operated animals. In ﬁve animals
without surgery the brains were perfused
to obtain calibration measurements. The
solubilized tissue was transferred to reac-
tion tubes and digested with PNGase
according to the standard protocol of the
manufacturer (Roche Diagnostics, Pen-
zberg, Germany). Digestion was stopped
by the addition of modiﬁed Laemmli sam-
ple buffer and boiling for 10 minutes. Five
microliters of each sample was subjected to
Western blotting. Proteins were separated
on 12% SDS-PAGE (NuPAGE, Invitro-
gen, Karlsruhe, Germany) and transferred
to PVDF membranes (Millipore, Esch-
born, Germany). After short blocking, the
membranes were incubated with the pri-
mary antibodies, 6H4 (Prionics, Schlieren,
Switzerland) and Actin I-19 (Biotechnol-
ogy, Heidelberg, Germany), separately,
over night. After incubation with primary
antibody, the membranes were incubated
with secondary antibodies, coupled to
alkaline phosphatase (DakoCytomation,
Hamburg, Germany).
The complete process was performed
with exact timing of the individual steps
and at a constant temperature to reach
maximum accuracy. For quantiﬁcation of
relative signal intensities, each Western
blot contained a dilution series of a stan-
dard protein with known concentration.
Intensity measurements were done with
Total Lab V 2.01 software (Nonlinear
Dynamics, Newcastle-upon-Tyne, UK).
The Western blots of actin were used as a
reference.
Statistical analysis.  Statistical analysis
was performed using the SPSS software
system (SPSS for Windows, Version 9.0,
SPSS, Inc., Chicago, IL, USA). The para-
metric T-test for unpaired samples was
used to determine signiﬁcant differences
between two groups. All P-values were
two sided and P <  0.05 was considered
signiﬁcant.
RESULTS
Characteristics of the ischemic brain
injury in Prnp
+ + + +/+ + + + and Prnp
− − − −/− − − − mice. Nissl-
stained sections from the brains subjected
to 1-h MCAO and 24-h reperfusion were
examined. Infarcts were clearly demarcated
in all experimental groups. The damaged
areas appeared as pale areas on gross
inspection (Figure 1A). Severe swelling of
the affected hemisphere with a correspond-
ing midline shift was noticed. Clearly
delineated lesions in the ischemic hemi-
sphere were found in all animals after 24 h
of reperfusion. Ischemic lesions extended
from the forebrain and few millimeters
past the bregma with the maximum extent
of the lesion at the level of the bregma.
Lesion volumes, measured by summa-
rizing delineated infarct areas in 500 µm
steps, were 10.06  mm
3 ± 4.8 mm
3  in
Prnp
+/+ mice and 34.78 mm
3 ± 12.99 mm
3
in  Prnp
−/−  mice (Figure  2A). The partial
volumes of the hemispheres were measured
from  −3.0 mm  to  +7.0  mm behind the
bregma, and were 50.19 mm
3 ± 19.5 mm
3
in the ipsilateral hemisphere and
50.89 mm
3 ± 19.88 mm
3  in the contra-
lateral hemisphere in Prnp
+/+  mice. In
Prnp
−/−  mice they were 86.45  mm
3 ±
18.4 mm
3 in the ipsilateral and 79.20 mm
3
± 15.03 mm
3  in the contralateral hemi-
sphere. Thus there was a much more
pronounced increase in volume in both
hemispheres in Prnp
−/−  than in Prnp
+/+
mice. The ratio of the infarct volume to the
ipsilateral hemisphere volume showed an
infarction of 39% ± 10% in Prnp
−/− mice
and 20% ± 3% in Prnp
+/+ mice. These dif-
ferences were signiﬁcant between Prnp
+/+
and Prnp
−/− mice (P < 0.05).
Anatomical distribution, appearance,
size and pattern of the infarct. During
evaluation of the infarct size we noticed
that various anatomical regions were
affected in different degrees in Prnp
+/+ and
Prnp
−/− mice. A more detailed comparison
Figure 2. A. Lesion volumes of Prnp
+/+ and Prnp
−/− mice after 1 h of ischemia and 24-h reperfusion.
Prnp
−/− mice (n = 9) show a more than three times larger lesion volume than Prnp
+/+ mice (n = 7). Data
are means ± standard deviation. *P < 0.05 (Student’s t-test). B. Neuroanatomical pattern of necrosis in
Prnp
+/+ and Prnp
−/− mice. The graph demonstrates the extent of the infarct over various anatomical
regions in the ischemic hemisphere at the level of the bregma. The affected areas in the piriform and
insular cortex were signiﬁcantly larger in Prnp
−/− than in Prnp
+/+ mice (*P < 0.05). Error bars indicate
standard errors of the mean; mean values are given in the table below.
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of sections at the level of the bregma
(Figure 2B) showed that the basal ganglia
were  most consistently and the most
severely affected; the area affected was
63% in Prnp
+/+ mice while it was 81% in
Prnp
−/−  mice. Twenty-ﬁve percent of the
motor cortex area was affected in Prnp
+/+
and 43% in Prnp
−/− mice. The highest diver-
sity was found in the piriform cortex with
8.3% in Prnp
+/+ and 67% in Prnp
−/− mice
followed by the insular cortex with 21% in
Prnp
+/+  and 67% in Prnp
−/−  mice. The
differences in the piriform cortex and the
insular cortex of Prnp
+/+ and Prnp
−/− mice
were  statistically signiﬁcant (P < 0.05).
Only 7.1% of the motor cortex was affected
in  Prnp
−/−  mice, whereas the cingulate
cortex was unaffected in Prnp
+/+ as well as
in Prnp
−/− mice. There were no pathologic
ﬁndings in paraventricular nuclei. In con-
clusion, the greatest variability was seen in
the piriform and the insular cortex.
Neurological evaluation. The neurolog-
ical examination was carried at two differ-
ent times, after 1 h of ischemia and at the
end of the 24-h reperfusion period. The
correlation between the mean neurological
score and mean number of necrotic neu-
rons after focal cerebral ischemia has
been described as highly signiﬁcant (7); a
decrease of the score stands for an increase
of clinical symptoms. A mean neurological
score of 18 points represents a healthy
mouse without clinical symptoms. The
mean neurological scores after 1  h of
ischemia were signiﬁcantly lower than
those after 24 h of reperfusion in Prnp
+/+
and Prnp
−/− mice (Figure 3A). While after
1 h of ischemia no differences were noted
between  Prnp
−/−  and  Prnp
+/+  mice, after
24-h reperfusion the scores of Prnp
−/− mice
were  signiﬁcantly lower compared with
Prnp
+/+ mice (P < 0.002).
RT-PCR analysis of Prnp transcription
after transient focal cerebral ischemia.
Following 1-h transient focal cerebral
ischemia and 24-h reperfusion in Prnp
+/+
animals three distinct areas were subjected
to investigation: (N) the region containing
the necrotic infarct area, (I) the region free
of infarct in the ipsilateral hemisphere and
(C) the region free of infarct in the con-
tralateral hemisphere. Transcription levels
of Prnp from these areas were analyzed by
QRT-PCR and were compared with the
corresponding ipsilateral (I) and the
contralateral hemispheres (C) of sham-
operated animals (Figure  3B). RT-PCR
analysis revealed a signiﬁcantly increased
expression of Prnp in the infarct-free region
of the ipsilateral hemisphere after ischemia
(P < 0.05). Prnp expression showed a slight
but nonsigniﬁcant increase in the con-
tralateral hemisphere. In contrast, PrP
C
mRNA levels were signiﬁcantly decreased
in the necrotic area (N) (P < 0.05), which
may be associated with the massive cell
death in this area.
Histology and immunohistochemistry.
In the Nissl-stained sections the nerve cells
in the infarct region showed pale staining
(Figure 1A). They appeared shrunken with
small pyknotic nuclei. Vacuolar changes
were also frequently observed. The poly-
clonal rabbit antibody directed against
recombinant full-length mouse PrP
(CDC1) reacted strongly in neurons and
sometimes glial cells in both gray and
white matter (Figure 1B). In gray matter
areas single strongly immunoreactive neu-
rons were observed predominantly in the
hippocampus and neocortex in MCAO
and control animals. In the necrotic infarct
area there was no PrP
C immunostaining. In
contrast, numerous neuronal cells in the
area surrounding the infarct region in the
ipsilateral hemisphere (I) showed a strong
PrP
C immunoreactivity, while other neu-
rons in the immediate vicinity did not
react (Figure 1C). Sections of Prnp
−/− mice
showed no reaction with the antibody
directed against PrP
C (Figure 1D).
Figure 3. A. Neurological scores (±standard deviation) in Prnp
+/+ and Prnp
−/− mice subjected to transient
middle cerebral artery occlusion after 1 h of ischemia (End of I1) and at the end of the 24-h lasting
reperfusion period (End of R24). No signiﬁcant differences were seen after 1 h of ischemia, although
there was a tendency for Prnp
−/− mice to perform less well. After 24-h reperfusion the scores of Prnp
−/−
mice were signiﬁcantly lower than in Prnp
+/+ mice. The asterisk indicates signiﬁcant difference (P < 0.002)
as determined by t-test. B. Quantitative reverse transcriptase polymerase chain reaction analysis of Prnp
gene transcription after 1  h of transient focal cerebral ischemia and 24-h reperfusion. The relative
transcription levels of Prnp and β-actin genes in the regions containing the necrotic infarct area (N) and
the region free of infarct of the ipsilateral hemispheres (I) as well as the expression levels in the con-
tralateral hemispheres (C) in ischemic animals are indicated by fold-changes as compared with the
corresponding regions of sham-operated animals (n = 4 for all groups). The asterisk indicates a signiﬁ-
cant increase in Prnp transcription in the ipsilateral hemisphere I and a signiﬁcant decrease in the
necrotic area N compared with sham-operated animals as determined by Student’s t-test (P < 0.05).
There is a tendency for increased Prnp transcription in the contralateral hemisphere C, which is statisti-
cally not signiﬁcant.
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Western blotting.  Western blots were
performed with tissue homogenates from
brain sections at the level of the bregma.
By  using the primary antibody 6H4,
which is directed against an epitope
within the ﬁrst alpha helix, full-length
unglycosylated PrP
C  (PrP
C  FL) was
detected at an apparent molecular weight
of 28.5  kDa. Two additional fragments
were observed at about 21.1 and 16.4 kDa
corresponding to the C2 and C1 frag-
ments described by Mangé (20). Reprob-
ing of Western blots with a primary
antibody against β-actin showed a band at
42.8 kDa.
In the samples extracted from the right
and left hemispheres of sham-operated
mice (Figure 4A; lanes Sham C and Sham
I) PrP
C FL represented the strongest signal,
whereas bands corresponding to the C1
fragment showed weaker staining. The C2
fragments were weaker but clearly discern-
ible. The expression level of β-actin was
similar in both hemispheres. In contrast to
this pattern, the necrotic infarct area (N)
of an ischemic mouse brain showed weak
staining for β-actin. PrP
C FL, C1 and the
C2 fragments were barely visible. In com-
parison with PrP
C  FL the C1 appeared
slightly stronger. Strong C1 bands were
also seen in the ipsilateral hemisphere not
affected by the infarct (I) and the contralat-
eral hemisphere (C) of ischemic mice.
These bands were not as intense as the
bands corresponding to PrP
C  FL, but
remarkably stronger than those represent-
ing the C1 fragment in sham-operated
mice.
The detected proteins were quantiﬁed
via comparison with a dilution series (not
shown). Figure 4B demonstrates the anal-
ysis of the ratio of C1 to PrP
C FL in sham-
operated (white columns) and ischemic
mice (dark columns). The ratio of the C1
fragment to PrP
C  FL was signiﬁcantly
increased in ischemic mice compared with
sham-operated animals in the ipsilateral
hemisphere I and contralateral hemisphere
C (P < 0.01).
C4/− − − − (PrP∆ ∆ ∆ ∆32–93) compared with 
Prnp
− − − −/− − − − mice
Infarct volume.  Lesion volumes mea-
sured by summarizing delineated infarct
areas in 500 µm steps were 33.54 mm
3±
14.93 mm




−/− mice after 24 h of
reperfusion (Figure 5A). The volume of the
hemispheres were measured from −3.0 mm
to  +7.0  mm behind the bregma, and
reached 86.44  mm
3 ± 29.28 mm
3  ipsila-
terally and 76.12 mm
3 ± 24.66 mm
3 con-
tralaterally in C4/−  mice. The brain
sections of Prnp
−/−  mice showed a
hemispheric volume of 82.31  mm
3 ±
26.26 mm
3 in the ipsilateral hemisphere
and 71.44 mm
3 ± 19.14 mm
3 in the con-
tralateral hemisphere. The ratio of ipsi-
lateral to contralateral hemisphere was
113% ±  6% in C4/−  mice and 114%  ±
10% in Prnp
−/− mice. These results signify a
shift to the contralateral hemisphere in
C4/− and Prnp
−/− mice and stand for serious
implications of the damage caused by tran-
sient MCAO in both strains in a similar
manner. The ratio of the infarct area to the
ipsilateral hemispheric volume showed inf-
arction with 37% ± 6% in C4/− mice and
39% ± 10% in Prnp
−/− mice. In conclusion,
there were no differences in infarct volume
and ratio of infarct volume to the ipsilateral
hemisphere between C4/−  and  Prnp
−/−
mice.
Neurological evaluation. The neurologi-
cal examination of C4/− vs. Prnp
−/− litter-
mates was carried at two different time
points, after 1 h of ischemia and at the end
of 24-h reperfusion. The mean neurologi-
cal scores of C4/− and Prnp
−/− mice after
1  h of ischemia were signiﬁcantly lower
than those after 24-h reperfusion, no sig-
niﬁcant difference was seen between the
C4/− mice and the Prnp
−/− mice, neither
after 1 h of ischemia nor at the end of 24-
h reperfusion (Figure 5B).
Histology and immunohistochemistry. In
both C4/− and Prnp
−/− mice, a remarkable
swelling of the ischemic hemisphere with
midline shift to the contralateral hemi-
sphere was observed in a similar manner.
After the 24-h reperfusion period, clearly
delineated lesions in the ischemic hemi-
sphere were found in both groups. In
C4/− and Prnp
−/− mice the ischemic lesions
began in the forebrain and ended a few
millimetres behind the bregma. Further-
more, C4/− and Prnp
−/− mice showed the
maximal extent of the lesion at the level of
Figure 4. Expression of cellular prion protein (PrP
C) and generation of cleavage products in Prnp
+/+ mice. A.
Western blots were performed with PNGase-digested tissue homogenates from the necrotic infarct area
(N), infarct-free brain tissue of the ipsilateral hemisphere (I) and contralateral hemisphere (C). A strong
band representing full-length PrP
C (PrP
C FL) was detected at about 28.5 kDa. Additional bands of lower
molecular weight can be observed at about 21.1  kDa, corresponding to the C2 fragment, and at
16.4 kDa, corresponding to the C1 fragment of PrP
C. As a reference the blots were reprobed with an
antibody directed against β-actin. PrP
C was found decreased in necrotic areas of ischemic mouse brains,
it was increased in non-necrotic areas of the ipsilateral and contralateral hemispheres. B. Densitometric
analysis of the ratio of C1/PrP
C full length reveals a signiﬁcant relative increase of C1 in both the necrotic
infarct area (N) and the infarct-free area of the ipsilateral hemisphere (I), and of the contralateral hemi-
sphere (C) in ischemic mouse brains (n = 7) in comparison with areas of sham-operated controls (n = 4).
Error bars indicate standard deviations. Signiﬁcant differences between ischemic and sham controls are
marked by an asterisk (**P < 0.01) as determined by Student’s t-test.
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the bregma. After focal cerebral ischemia
the necrotic lesion area in the ipsilateral
hemisphere of the C4/−  mice showed a
remarkably reduced immunoreactivity for
PrP and β-actin. The ipsilateral area sur-
rounding the infarct presented a punctate
PrP staining of intensely immunoreactive
neuronal cells in a pale environment as seen
in Prnp
+/+ mice (Figure 1F). Similar to sec-
tions of Prnp
+/+  mice, C4/−  mice had
indicated strongly PrP immunoreactive
neurons predominantly in the hippocam-
pal formation and cerebral cortex. An over-
all weak staining in the corpus callosum
and basal ganglia was observed, while most
immunoreactivity was found again in the
hippocampus and piriform gyrus. In com-
parison, no reaction with the antibody
directed against PrP was detected in the
frozen sections of the Prnp
−/−  littermates
(Figure 1G).  β-Actin immunoreactivity
was observed in C4/−  and  Prnp
−/−  mice
overall in an analogous manner. Both
strains showed strong staining in the basal
ganglia and outer layers of the cortex and
weaker staining in the corpus callosum.
Western blotting analysis of PrP
C  after
MCAO. Figure 6A shows Western blots of
PNGase-digested identical brain samples
of ischemic C4/− mice (N, I and C) and
corresponding areas in C4/− sham control
animals with homogenates from brain sec-
tions at the level of the bregma. Antibody
6H4 was used as primary antibody, which
is directed against an epitope within the
ﬁrst alpha helix of PrP
C. Only two bands
at about 20.1 and 16.4 kDa are seen cor-
responding to the full-length C4 protein
and the C1 fragment, whereas no isolated
C2 fragment is discernible. In comparison
with C4 FL the C1 fragments appeared
slightly stronger in necrotic and in the ipsi-
lateral hemisphere not affected by the inf-
arct (I) after MCAO damage in C4/− mice
but a C2 fragment is not detectable in
C4/− mice. In the samples extracted from
the ipsi- and the contralateral hemispheres
of sham-operated C4/− mice (Figure 6A;
lanes Sham I and Sham C) C4 FL and
bands corresponding to the C1 fragment
do not differ in intensity but they are
remarkably weaker compared with the
ischemic areas I and C. There are differ-
ences of PrP full length and C1 signal
intensities between ischemic Prnp
+/+  and
C4/− mice because of the 1.5 times higher
PrP expression in C4/− mice (Figure 6B).
DISCUSSION
In  this study we ﬁrst compared the
lesion proﬁle and extent of tissue damage
in Prnp
+/+ and Prnp
−/− mouse brains after
transient focal ischemia. As shown before,
Prnp
−/− mice have a tendency to larger inf-
arct size when compared with Prnp
+/+ ani-
mals (21, 31, 37). Our QRT-PCR analysis
of Prnp gene expression after 1-h transient
focal cerebral ischemia and 24-h reperfu-
sion indicated distinct local differences in
Prnp
+/+ mouse brains. We found a decrease
in Prnp expression in the lesion area while
the infarct-free region around the lesion of
the ipsilateral hemisphere showed a signif-
icant increase. A slight but nonsigniﬁcant
increase of PrP
C  mRNA levels was
found in the contralateral hemisphere.
The decrease of PrP
C mRNA levels in the
necrotic area is readily explained by the
large number of dying cells in this area.
The up-regulation of PrP
C mRNA levels in
the area adjacent to the infarct may be
triggered by local oxidative damage and
other metabolic derangements in this area;
this would be in keeping with in vitro
analyses showing a correlation between
PrP expression and oxidative stress (3).
The neuronal histology in the region of
ischemic injury indicated oxidative dam-
age and cell death. Intense PrP
C  immu-
noreactivity was seen in individual cells in
the penumbra, while other neurons in this
area showed no PrP
C immunoreactivity.
The role of PrP
C FL in neuroprotection
and in particular in reversing the oxidative
stress damage is well documented (15, 23,
27, 39). In this study we detected an
increased degradation of PrP
C  FL to its
breakdown product C1 in the area sur-
rounding the infarct and in the contralat-
eral hemisphere in Prnp
+/+ mouse brains.
This ﬁnding is in agreement with Mangé’s
postulation of increased PrP
C degradation
under oxidative conditions (20). It is
tempting to speculate that PrP
C  overex-
pression increases the chances for neuronal
survival under the conditions of oxidative
stress while lack of PrP
C  facilitates cell
death. However, the cascade may be more
complex; volumetric analyses of mouse
brains overexpressing PrP
C (tga20 line) did
not show enhanced neuroprotection com-
pared with wild-type control animals after
ischemia (31). Disproportionate availabil-
ity of downstream ligands may have an
impact on the neuroprotective ability of
Figure 5. A. Lesion volumes of C4/− and Prnp
−/− mice after 1 h of ischemia and 24-h reperfusion. There
are no signiﬁcant differences between C4/− and Prnp
−/− mice. Data are means ± standard deviation; n = 8
animals/group.  B.  Neurological scores (±standard deviation) in C4/−  and  Prnp
−/−  mice subjected to
transient middle cerebral artery occlusion after 1 h of ischemia (End of I1) and at the end of the 24-h
lasting reperfusion period (End of R24). No signiﬁcant differences in the neurological score were found
at I1 and R24.
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PrP. A number of proteins, for example, the
neuronal cell adhesion molecule (29), the
stress-inducible protein 1 (19) or the lami-
nin receptor and laminin receptor precur-
sor protein (8, 11), have been postulated
as potential interaction partners. It is also
possible that PrP acts as a regulator of cyto-
solic signaling pathways. Increased activity
of cell signaling factors involved in cell
survival and apoptosis such as ERK-1/-2,
STAT-1 and caspase-3 were found in
Prnp
−/− mice (31, 38). At present it is dif-
ﬁcult to decide whether the extent and
severity of ischemia are a cause or a conse-
quence of altered signaling pathways.
In previous cell culture studies we dem-
onstrated that oxidative stress together
with PrP
C  elicited a signaling cascade
involving PI3K (33). PI3K signaling
increased the survival chances of PrP
C-
expressing cells. PI3K has been shown to
be sensitive to redox signaling by superox-
ide and hydrogen peroxide and to be acti-
vated by copper ions (24). This effect may
be mediated or initiated by PrP. In our
experiments this interaction could not be
initiated by PrP lacking the octapeptide
and ﬂanking amino acids (PrP∆32–93).
Other studies (36) have demonstrated that
the octapeptide repeat region of PrP
C  is
required for reactive oxygen species-
mediated  β  cleavage of PrP
C  and cells
lacking the octapeptide region are more
susceptible to oxidative stress.
As our previous cell culture experiments
pointed towards the neuroprotective effect
of the N-terminal octapeptide repeat
region (5) we were interested to investigate
this effect in vivo  using the established
focal ischemia model. Therefore, we
subjected transgenic C4/−  mice to con-
trolled ischemia by MCAO and reper-
fusion. C4/−  mice lack the N-terminal
octapeptide region (amino acids 51 to 91)
and N-terminally ﬂanking amino acids
(PrP∆32–93) and have been described as
phenotypically normal under standard
conditions but develop atypical disease
when infected with scrapie prions (6). We
show that in the focal ischemia model
animals lacking the octapeptide of PrP
(PrP∆32–93) behave like Prnp
−/−  mice.
Thus, in our model the C4 protein
(PrP∆32–93) does not functionally rescue
the Prnp
−/− phenotype. However, the pre-
cise mechanism of the PrP
C-dependent
neuroprotection remains to be elucidated.
On one hand studies have shown (28)
that Prnp
−/− neuronal cells expressing PrP
C
lacking the N-terminal octapeptide repeat
region (amino acids 53–94) show
enhanced apoptosis and decreased super-
oxide dismutase activity. In accordance
with these ﬁndings Bounhar et al (2) dem-
onstrated that PrP
C potently inhibits Bax-
induced cell death in human primary
neurons and while the deletion of four
octapeptide repeats of PrP
C  completely
eliminates the neuroprotective effect of
PrP
C, PrP lacking the glycosylphosphati-
dylinositol anchor signal peptide remains
anti-apoptotic.
On  the other hand the N-terminal
octapeptide region of PrP
C has been shown
to bind copper in a cooperative manner (1,
26, 34). The most obvious train of argu-
ments would invoke the copper-binding
ability of PrP
C and its involvement in cell
signaling, oxidative stress and the contribu-
tion to cell survival under stress conditions
(33). PrP
C does not seem to be involved in
copper transport at the synapse (10). Thus
it would appear that PrP
C is a sensor for
oxidative stress, which may function in
conjunction with copper binding to the N-
terminal octarepeat.
Sequence analysis by Chen et al (4) ﬁrst
detected a glycosylated, cell membrane-
anchored major product, designated C1
that is generated by a cleavage at position
111/112 (α cleavage), as well as an addi-
tional fragment longer than C1, termed
C2 which is created by β cleavage. These
cleaving processes seem to be copper
dependent (32). Interestingly, our Western
blotting analyses showed that in C4/− mice
there is an increase of the α cleavage in
ischemic brain regions compared with
sham-operated C4/− control animals. This
ﬁnding indicates that the C1 fragment is
not likely to be linked to the neuroprotec-
tive function of PrP
C. Furthermore, in
agreement with Watt and Hooper (36) no
fragments at about 21.1 kDa correspond-
ing to the C2 cleavage products were
detectable in C4/− mice. As the β site is
located in the octapeptide repeat region
(22), the absence of a β cleavage in the
octapeptide repeat region and its break-
Figure 6. Expression of cellular prion protein (PrP
C) and generation of cleavage products in C4/−  and
Prnp
+/+ mice. The Western blots were performed with PNGase-digested homogenates of sham-operated
C4/− mice and the three different brain regions of C4/− and Prnp
+/+ mice after ischemic injury (N, I and
C). A. Dominant bands of C4 full-length (C4 FL) are detected at about 20.1 kDa in C4/− sham control
mice. At about 16.4 kDa there are weaker bands that correspond to the C1 fragments in C4/− mouse
brain homogenates. After middle cerebral artery occlusion (MCAO) damage in C4/− mice there is an
increase in α cleavage in the three regions investigated (N, I, C). Two bands at about 20.1 and 16.4 kDa
are seen corresponding to full-length C4 protein and the C1 fragment. The signal intensities of C1
fragments in ischemic C4/− mice are remarkably stronger than those representing the C1 fragment in
sham-operated control mice. A C2 fragment is not discernible. B. A clear band of full-length PrP
C (PrP
C
FL) is detected at about 28.5 kDa in Prnp
+/+ mice and about 20.1 kDa in C4/− mice. An additional band
is seen at 21.1 kDa in the Prnp
+/+ lanes corresponding to the C2 fragment. The C2 fragment of PrP
C
migrates approximately at the same molecular weight as the full-length C4 protein (PrP∆32–93). A C2
fragment is not discernible in C4/− mice. At about 16.4 kDa there are dominant bands that correspond
to the C1 fragments in Prnp
+/+ and C4/− mouse brain homogenates after MCAO damage.
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down products in C4/−  mice must be
expected. In accordance with our data,
McMahon et al (22) found a decrease of
PrP
C FL and an increase of amino-termi-
nally fragmented PrP
C in cells under oxi-
dative stress. Furthermore they reported
that the octapeptide repeat region of PrP
C
undergoes a site-speciﬁc copper- and pH-
dependent cleavage, which has vast impli-
cations for further proteolysis.
Mangé and coworkers (20) argued that
PrP
C is ﬁrst cleaved at the β site in the
octapeptide region and near the histidine
in position 96, followed by a rapid second
cleavage in the α site, which inactivates the
biological active form of PrP cleaved at the
β  site. This is in line with data of our
experiments, where bands corresponding
to the C2 fragments appeared to decrease
in Prnp
+/+ ischemic mouse brains, whereas
an increase of bands corresponding to the
C1 fragments was visible compared with
Prnp
+/+ sham controls. In mice expressing
PrP∆32–93 remarkably stronger bands
representing the C1 fragments were detect-
able in ischemic brain areas compared with
C4/−  sham controls as well. Although
C4/−  mice express 1.5 times more PrP
than wild-type mice and show an increase
of C1 fragments under oxidative stress
conditions, they fail to rescue the Prnp
−/−
phenotype. Therefore our ﬁndings show
that mice expressing PrP∆32–93 were able
to provide C1 terminal fragments indepen-
dent of previous cleavage at the β site in
the octapeptide region but the C1 frag-
ments have no protective role.
Taken together our data support the
hypothesis that absence of cleavage at the
β site, which is possibly facilitated by cop-
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